Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration Nonexudative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01866371
What this trial is testing

High Resolution Retinal Imaging

Who this might be right for
StargardtsRetinitis PigmentosaAge-related Macular Degeneration+2 more
University of Pennsylvania 600
Not applicableLooking for participantsNCT03921931
What this trial is testing

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Who this might be right for
Macular Degeneration, DryPrimary Open-angle Glaucoma
Medical University of Vienna 35
Not applicableLooking for participantsNCT05959005
What this trial is testing

Progression of Early Atrophic Lesions

Who this might be right for
Age-Related Macular Degeneration
University of Utah 125
Early research (Phase 1)Looking for participantsNCT07230834
What this trial is testing

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

Who this might be right for
Geographic Atrophy (GA)
Regeneron Pharmaceuticals 54
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Not applicableStudy completedNCT01890187
What this trial is testing

Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium

Who this might be right for
Advanced Dry AMD With Geographic Atrophy
Carl Zeiss Meditec, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT06769048
What this trial is testing

Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 150
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807969
What this trial is testing

An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Annexon, Inc. 605
Large-scale testing (Phase 3)Study completedNCT04770545
What this trial is testing

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 792
Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Not applicableEnrolling By InvitationNCT07170683
What this trial is testing

Microperimetry Changes in Retinal Function in Macular Disorders

Who this might be right for
Dry AMDDiabetic Retinopathy (DR)
University of Nottingham 200
Early research (Phase 1)WithdrawnNCT01093170
What this trial is testing

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Mark Kleinman
Large-scale testing (Phase 3)Study completedNCT03525600
What this trial is testing

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 621
Large-scale testing (Phase 3)Study completedNCT04636853
What this trial is testing

CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration

Who this might be right for
Retinitis PigmentosaDry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Testing effectiveness (Phase 2)Looking for participantsNCT06765980
What this trial is testing

Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Kriya Therapeutics, Inc. 62
Testing effectiveness (Phase 2)Looking for participantsNCT04292080
What this trial is testing

Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy

Who this might be right for
Age-related Macular Degeneration (AMD)
Assistance Publique - Hôpitaux de Paris 90
Not applicableStudy completedNCT02264938
What this trial is testing

Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation

Who this might be right for
Macular Degeneration
Germans Trias i Pujol Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01445548
What this trial is testing

Sirolimus for Advanced Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 6
Next Page